Search Results - Ki-Young Huh

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration by Sungyeun Bae, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, Anhye Kim

Connect to this object online.

Exploration of smart adherence‐monitoring methods in vitamin D‐deficient patients: A pilot feasibility clinical study by Ki Young Huh, Hwiwon Lee, SeungHwan Lee, Kyung‐Sang Yu, Kyung Hwan Kim, Heejin Kim

Connect to this object online.

Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019 by Ki Young Huh, Eunwoo Kim, Soyoung Lee, Hyounggyoon Yoo, Seonghae Yoon, Kyung-Sang Yu, Jae-Yong Chung

Connect to this object online.

Estimation of the benefit from pre‐emptive genotyping based on the nationwide cohort data in South Korea by Ki Young Huh, Sejung Hwang, Joo Young Na, Kyung‐Sang Yu, In‐Jin Jang, Jae‐Yong Chung, Seonghae Yoon

Connect to this object online.

Pharmacokinetics and tolerability of apremilast in healthy Korean adult men by Ki Young Huh, Yewon Choi, Jim Nissel, Maria Palmisano, Xiaomin Wang, Liangang Liu, Francisco Ramirez‐Valle, Howard Lee

Connect to this object online.

Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese by Eunsol Yang, Jung Sunwoo, Ki Young Huh, Yu Kyong Kim, SeungHwan Lee, In‐Jin Jang, Kyung‐Sang Yu

Connect to this object online.

Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms by Ki Young Huh, Woo Kyung Chung, Jiyeon Park, SeungHwan Lee, Min‐Gul Kim, Jaeseong Oh, Kyung‐Sang Yu

Connect to this object online.

Evaluation of a blockchain‐based dynamic consent platform (METORY) in a decentralized and multicenter clinical trial using virtual drugs by Ki Young Huh, Seol Ju Moon, Sang‐un Jeong, Min‐Ji Kim, Wooseok Yang, Myeonggyu Jeong, Min‐Gul Kim, SeungHwan Lee

Connect to this object online.

A phase I study to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic profiles of ocular GLH8NDE in healthy male adults by Jihyun Jung, Ki Young Huh, Xuanyou Jin, Ahnul Ha, Ki Ho Park, Jun Sang Park, Eunjung Kim, Jaehwi Lee, In‐Jin Jang, Howard Lee

Connect to this object online.

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib by Ki-Young Huh, Se-jung Hwang, Sang-Yeob Park, Hye-Jung Lim, Mir-yung Jin, Jae-seong Oh, Kyung-Sang Yu, Jae-Yong Chung

Connect to this object online.

Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects by Joo Young Na, Ki Young Huh, Kyung‐Sang Yu, Joon Young Hyon, Hye Cheong Koo, Jong Ho Lee, Ji Chang You, Jae‐Yong Chung

Connect to this object online.

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses by Sang-Hwan Ji, Sang-Hwan Ji, Ki Young Huh, Ki Young Huh, Jaeseong Oh, Jaeseong Oh, Hee-Jeong Jeong, Hee-Jeong Jeong, Young-Eun Jang, Young-Eun Jang, Eun-Hee Kim, Eun-Hee Kim, Ji-Hyun Lee, Ji-Hyun Lee, Jin-Tae Kim, Jin-Tae Kim, Hee-Soo Kim, Hee-Soo Kim

Connect to this object online.

The necessary conduct: Exploratory multiregional clinical trials in East Asia by Inseung Jeon, Yu Kyong Kim, Ildae Song, Deok Yong Yoon, Ki Young Huh, Xuanyou Jin, Kyung‐Sang Yu, SeungHwan Lee, Yuji Kumagai, In‐Jin Jang

Connect to this object online.

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis by Sang‐Hwan Ji, Ki Young Huh, Jaeseong Oh, Hee‐Jeong Jeong, Young‐Eun Jang, Eun‐Hee Kim, Ji‐Hyun Lee, Jin‐Tae Kim, Hee‐Soo Kim

Connect to this object online.